Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Regulatory & Reimbursement

Action Packed in the EU, FDA AI Guide, and Global Picks

In this week’s Pathways Picks: In the EU, nine member states propose an MDR reform framework, the first centralized clinical investigation database is launched, a EUDAMED Q&A is posted, and notified bodies weigh in on artificial intelligence; at the FDA, a final guide on predetermined change control plans for AI, a key promotion, and ethylene oxide policies; and medtech policy updates from the UK, China, and Brazil.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Action Packed in the EU, FDA AI Guide, and Global Picks

In this week’s Pathways Picks: In the EU, nine member states propose an MDR reform framework, the first centralized clinical investigation database is launched, a EUDAMED Q&A is posted, and notified bodies weigh in on artificial intelligence; at the FDA, a final guide on predetermined change control plans for AI, a key promotion, and ethylene oxide policies; and medtech policy updates from the UK, China, and Brazil.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


First Takes

MDR Reform Efforts Advance As a New EU Term Begins

Nine European countries presented a top-line MDR/IVDR reform proposal to the EU Council that would give more centralized device authority to the European Medicines Agency and seek to remove some “administrative obligations” for companies. The proposal comes at the start of a new term of the European Commission that includes a remit to consider legislative changes to the device regulations.

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More